Biocon’s robust Regulatory team is fully equipped to develop regulatory strategy and manage compliance, risks and dossier submissions across the globe. The team leverages the obtained regulatory approvals to penetrate new markets quickly and cost effectively.

The API team has 55+ APIs, 600+ DMFs, and 30+CEPs or equivalent to their credit, which span the US, EU, Australia, Canada, Japan, China, S. Korea, Brazil, Russia, Mexico, GCC countries, other MOW markets, and 500+ domestic and multi-national customers. Our Finished Products team has established a strong footprint in the US, EU, Canada, China, and Brazil, having submitted over 50+ products to these markets, and a pipeline that stands strong. Our focus now includes other global markets.